CiiTA provides expertise and actionable intelligence to pharmaceutical and biotechnology manufacturers and other participants in the 340B Drug Pricing Program. We use both our unique and in-depth knowledge of 340B Program regulations and our uniquely tailored research and data programs to assist manufacturers with the complexities of managing